Executive Team
Pritesh Gandhi, PharmD
Chief Executive Officer
Pritesh Gandhi has a broad range of experiences in academia and the biopharmaceutical industry. Previously, he was General Manager at Alnylam Pharmaceuticals where he led cross-functional teams to bring forward a rare disease medicine from Phase 1/2 development to global commercialization. Earlier at Alnylam, Pritesh was responsible for building a world-class global medical affairs vision, strategy, and operational capability to launch two novel RNAi therapeutics. Prior to joining Alnylam, Pritesh had a wide-range of global medical affairs responsibilities in launching four first-in-class medicines in hematology/oncology at Genzyme Corporation (Sanofi Genzyme).
Pritesh launched his professional career in the biopharmaceutical industry at Millennium and then Alexion. He commenced his professional journey in academia with faculty appointments at Massachusetts College of Pharmacy and The University of Massachusetts Medical School where he conducted scholarly work and contributed to the medical literature.
Pritesh graduated with a Doctor of Pharmacy degree from Massachusetts College of Pharmacy and completed a residency at the University of Illinois at Chicago. He has received multiple awards for excellence in teaching, leadership, and community service.
Annie Partisano, PharmD, MS
SVP, Head of Operations
Angela (Annie) Partisano comes to TellBio with over 15 years of pharmaceutical industry experience in both pre-commercial and commercial companies. Previously, she was Vice President of Medical Operations at Kiniksa Pharmaceuticals, Ltd., where she was responsible for the operational growth of the Medical Affairs team. Prior to joining Kiniksa, Annie held several positions of increasing responsibility within the Medical Affairs team at Alnylam Pharmaceuticals where she helped build a world-class global medical affairs vision, strategy, and operational capability and supported the launch of two novel RNAi therapeutics. Earlier in her career, Annie held leadership positions within the Medical Affairs teams at Genzyme Corporation (Sanofi Genzyme) and Boehringer Ingelheim Pharmaceuticals, Inc.
During her professional career, Annie has been recognized for establishing industry leading Medical functions as well as top-tier Medical Affairs Post-PharmD Fellowship programs in the Boston area. In 2018, Annie was named one of the Healthcare Businesswomen’s Association (HBA) Rising Star for her noteworthy achievements within the pharmaceutical industry.
Annie received her Doctor of Pharmacy degree as well as her Master of Science (Regulatory Affairs) from Northeastern University and completed post-doctorate residencies at the University of Rochester and Purdue University/Eli Lilly.
BOARD OF DIRECTORS
Richard Peters, MD, PhD
Executive Chairman, TellBio
Chairman, Pharming Group
Chairman, Aprea Therapeutics
Director, Kineta
Gary Crocker, MBA
Director, TellBio
President, Crocker Ventures
Chairman, Merrimack Pharmaceuticals
Chairman, Nexus Spine
Bernard Peters, MIBS
Director, TellBio
Chief Financial Officer, Sloan
President, Sloan Flushmate
Pritesh Gandhi, PharmD
Chief Executive Officer, TellBio
FOUNDERS
Richard Peters, MD, PhD
Executive Chairman, TellBio
Chairman, Pharming Group
Chairman, Aprea Therapeutics
Director, Kineta
Daniel Haber, MD, PhD
Director, Massachusetts General Hospital Cancer Center
Professor of Oncology, Harvard Medical School
Mehmet Toner, PhD
Co-Director, MGH Center for Engineering in Medicine & Surgery
Professor of Biomedical Engineering, Harvard Medical School
David Ting, MD
Associate Professor, Massachusetts General Hospital and Harvard Medical School
Associate Clinical Director for Innovation, Massachusetts General Hospital Cancer Center
Shyamala Maheswaran, PhD
Professor of Surgery, Harvard Medical School
Scientific Director, Massachusetts General Hospital Laboratory for CTC Innovation
Ravi Kapur, PhD
CEO, BendBio Inc.
President, Boston Nanotech Inc.